Barbara Browder
Psychiatric/Mental Health · Glendale, AZNPI 1740702901
Payments from drug & device makers
Across 99 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$497
- Vanda Pharmaceuticals Inc.$314
- Axsome Therapeutics, Inc.$226
- Otsuka America Pharmaceutical, Inc.$205
- Alkermes, Inc.$193
- Johnson & Johnson$156
- plus $650 from 11 others
What the payments were for
- Food & beverage$2,240100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $497 |
| Vanda Pharmaceuticals Inc. | 7 | $314 |
| Axsome Therapeutics, Inc. | 6 | $226 |
| Otsuka America Pharmaceutical, Inc. | 10 | $205 |
| Alkermes, Inc. | 6 | $193 |
| Johnson & Johnson | 3 | $156 |
| Lundbeck LLC | 6 | $138 |
| Neurocrine Biosciences, Inc. | 1 | $112 |
| Corium, LLC | 7 | $108 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Tris Pharma Inc | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Tempus AI, Inc | 1 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,240 in reported general payments places this provider in the 80th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 17 | $212 |
| Escitalopram Oxalate | 14 | $197 |
| Bupropion XlBupropion Hcl | 16 | $158 |
| Trazodone Hcl | 17 | $141 |
| Gabapentin | 14 | $108 |
| Duloxetine Hcl | 12 | $107 |
| Alprazolam | 21 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $15 | $21217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Glendale
- Barbara KayiiraGlendale$10K
- Curtis AndrewsGlendale$9K
- Lydia VerattiGlendale$9K
- Lizy WindsorGlendale$8K
- Sarbjit SinghGlendale$6K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
- Russell HorningPhoenix$254K
- Stacy UnderwoodMesa$252K
- Angela ChenTempe$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.